Dr. John Staffurth

Dr. John Staffurth

Cancer Specialist - Radiation Oncologist,Surgical Oncologist

  Rutherford Cancer Center, South Wales, London, United Kingdom

  24 Years of experience

BIOGRAPHY

Dr. John Staffurth is one of the finest Cancer Specialist in United Kingdom. He is an experienced Radiation Oncologist in the United Kingdom. The Medical practitioner has been associated with various reputed hospitals in the United Kingdom. The physician is currently working as a Consultant Clinical Oncologist, Rutherford Cancer Center, South Wales, United Kingdom. The doctor is a well-reputed and sought after medical expert and is

  • His clinical base is at Velindre Cancer Centre and the University Hospital of Wales and his academic base is at Cardiff University where he is Reader in Oncology in Professor Malcolm Mason’s research group.

qualified. Dr. John Staffurth has been associated with many hospitals over the course of his illustrious and experienced career.

The hospitals include:

  • He moved to the Royal Marsden in 1999 and joined the Academic Urology Unit in 2000 taking an MD in IMRT in Pelvic Malignancies at the Institute of Cancer Research.

Dr. John Staffurth has more than 24 Years of clinic experience. The Clinician specializes in and performs the following surgeries:

  • Intensity-modulated radiotherapy (IMRT)
  • Prostate Cancer Treatment
  • Stereotactic Radio Therapy (SRT)
  • Oncology
CERTIFICATIONS (2)
  • He trained at Guys Hospital, qualified in 1992 and started clinical oncology training in 1996.
MEMBERSHIPS (3)
  • Fellow Royal College of Radiologists
  • Fellow of Royal College of Physicians of London
  • Fellow of Royal College of Physicians of Edinburgh
RESEARCH PAPERS AND PUBLICATIONS (5)
  • A Screening Tool for the Detection of Gastroenterological Late Effects after Radiotherapy for Prostate Cancer
  • Driving developments in UK oesophageal radiotherapy through the SCOPE trials
  • Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
  • 110 The trigger project: introducing electronic patient reported outcome measures into radiotherapy services
  • Patient Reported Acute Toxicity in PACE-B, an International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy to Conventionally Fractionated or Moderately Hypofractionated Radiotherapy (CFMHRT) for Localised Prostate Cancer
Procedures
Intensity-modulated radiotherapy (IMRT)

Intensity-modulated radiotherapy (IMRT) is a type of conformal radiotherapy, a technology that enables the radiation oncologist to precisely target the tissues with cancer cells. . In this type of radiation therapy for cancer, the radiation beams closely take up the shape of the area that is being targeted.

IMRT is delivered through the standard radiotherapy machine, which is also known as the linear accelerator (LINAC). This machine has a device called multileaf collimator, which possesses lead leaves that can move independently to form a shape that best fits the target area.

Because the radiation beams can take up the shape of the target area, high dosage of radiation can be delivered to kill the cancer cells while minimizing exposure to the non-cancerous cells and tissues. IMRT proves to be highly effective in the case of head and neck cancer among other types of cancer.IMRT for prostate cancer is now available across all major hospitals around the world.

The efficiency of IMRT has already been tested for multiple cancers, including breast cancer. Latest advancements improving the efficacy of radiotherapy, however, continue to take place in the field of healthcare. This radiation treatment for cancer is already being used as a standard treatment for some cancer types.

Prostate Cancer Treatment

The prostate is a gland in the male reproductive system, which makes fluid that forms an essential part of the semen. Prostate cancer starts when cells of the prostate glands begin to grow abnormally

Prostate cancer is one of the leading cancers in men above the age of 60. In most of the cases, it is slow growing and may even go undetected and do not cause any problem. However, in some cases, it could be aggressive and cancer cells can spread to other parts of the body (metastatic prostate cancer)

Prostate cancer is a very slow growing disease and starts with tiny alterations in the shape and size of the prostate gland cells. The prostate cancer risk increases with age and it is rarely observed before the age of 40. That is the main reason why many men die of old age, without ever knowing that they had prostate cancer.

Prostate Cancer Causes

There is no direct prostate cancer causes. However, there are some factors that can increase the risk of prostate cancer, including the following:

  • Consumption of diet rich in red meat and high fat dairy products
  • Less consumption of vegetables and fruits
  • Obesity
  • Family history of the disease
  • Smoking and alcohol consumption
  • Sexually transmitted infections

Types of Prostate Cancer

Usually, prostate cancer means the cancer of prostate gland cells called prostatic intraepithelial neoplasia (PIN). Almost all the prostate cancers are adenocarcinomas, but there are some other types of prostate cancer as well, including the following:

  • Sarcomas
  • Small-cell carcinomas
  • Neuroendocrine tumors (other than small cell carcinomas)
  • Transitional cell carcinomas

Prostate Cancer Classification

Based on how abnormal the patterns of cancer cells look, prostate cancers are classified as:

  • Low-grade PIN: In this, the pattern of prostate cells appears almost normal
  • High-grade PIN: In this, the pattern of cells looks a bit abnormal

Signs of Prostate Cancer

There are no warning signs of prostate cancer. The symptoms of metastatic prostate cancer usually appear first in the region that the cancer cells have invaded.

After cancer causes the prostate gland to swell, the following signs of prostate cancer may be experienced: 

  • Frequent urination, especially at night
  • Difficulty starting or stopping the stream of urine
  • Weak urine stream and inability to urinate
  • Pain and burning sensation during urination and ejaculation
  • Blood in urine or semen

In prostate cancer stages, the following symptoms may also be there:

  • Pain in spine, pelvis or ribs
  • Leg weakness
  • Urinary incontinence
  • Fecal incontinence
Stereotactic Radio Therapy (SRT)

Stereotactic radiotherapy (SRT) is a type of technique used to precisely target radiation beams at the tumour. This is one of the latest innovations in the field of radiation therapy. Since this treatment requires special equipment, machine, and expertise, this treatment is not widely available across all cancer treatment hospitals.

SRT involves treatment of a tumour with the help of a special machine known as a linear accelerator (LINAC). This machine is used to deliver external radiation therapy in the case of normal radiation therapy and intensity-modulated radiation therapy (IMRT).

SRT treatment involves of small daily doses of radiation, which are also known as fractions. The patient may be advised to undergo anywhere between 3 to 30 fractions in a day, depending on the extent of cancer and the size of the area that is being targeted. SRT is mostly used for the treatment of smaller lesions and tumours and is less than 3 cms in size.

Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are types of SRT. SRS is also known as Gamma Knife surgery. It involves exposing the tumour to a very high dose of radiation in one to five fractions. Gamma Knife surgery is usually used for the treatment of a tumour in the central nervous system (CNS).

On the other hand, SBRT is a special procedure used for the treatment of tumours located outside the central nervous system. In this approach, radiation is delivered through different directions or positions of the body. It can be used for the treatment of small tumours in the lungs, pelvis, prostate, pancreas and other organs as well.

SRT is mostly used for the treatment of the following conditions:

  • Secondary brain tumours
  • Small lesion or brain tumour that has a well-defined edge
  • Glioma that may have returned after months or years of treatment

Gamma Knife surgery is different from CyberKnife radiation. The latter is used for the treatment of cancerous and non-cancerous tumours as well as other medical conditions. CyberKnife treatment is actually a frameless robotic radiosurgery system that delivers a high dose of radiation to the targeted location.

Frequently Asked Questions
What area of specialization does Dr. John Staffurth have?
Dr. John Staffurth is specialized in United Kingdom and of the most sought after doctors in Cancer Specialist.
Does Dr. John Staffurth offer Telemedicine Consultation through Medigence?
No, this doctor dose not offer telemedicine via MediGence
How many years of experience does Dr. John Staffurth have?
Dr. John Staffurth is one of the most sought after specialists in United Kingdom and has over 24 Years years of experience.
Please Enquire
   Telemedicine Doctors
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Popular Packages offered by Cancer Specialist
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Our team of healthcare experts would be happy to assist you

Get In Touch
or call

(+1) 424 283 4838